CDD3506
CAS No. 197913-15-8
CDD3506( 1-TRITYL-1H-IMIDAZOL-4-AMINE )
Catalog No. M26554 CAS No. 197913-15-8
CDD3506 increases high-density lipoprotein cholesterol by targeting hepatic CYP3A.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 79 | Get Quote |
|
| 5MG | 132 | Get Quote |
|
| 10MG | 213 | Get Quote |
|
| 25MG | 430 | Get Quote |
|
| 50MG | 624 | Get Quote |
|
| 100MG | 888 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCDD3506
-
NoteResearch use only, not for human use.
-
Brief DescriptionCDD3506 increases high-density lipoprotein cholesterol by targeting hepatic CYP3A.
-
DescriptionCDD3506 increases high-density lipoprotein cholesterol by targeting hepatic CYP3A.
-
In VitroCDD3506 specifically induces hepatic cytochrome P450IIIA produces significant increases in HDL cholesterol.
-
In Vivo——
-
Synonyms1-TRITYL-1H-IMIDAZOL-4-AMINE
-
PathwayMetabolic Enzyme/Protease
-
TargetP450
-
RecptorGPR109A| GPR109B
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number197913-15-8
-
Formula Weight325.415
-
Molecular FormulaC22H19N3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 19 mg/mL (58.39 mM)
-
SMILESNc1cn(cn1)C(c1ccccc1)(c1ccccc1)c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Jacobson MK, et al. Effect of myristyl nicotinate on retinoic acid therapy for facial photodamage. Exp Dermatol. 2007 Nov;16(11):927-35.
molnova catalog
related products
-
ε-?Viniferin
ε-Viniferin a dimer of resveratrol, shows the inhibitory effects of epsilon-viniferin on human CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2B6, CYP2E1, CYP3A4 and CYP4A activities.
-
Piperonylic acid
Piperonylic acid is a natural molecule bearing a methylenedioxy function that closely mimics the structure of trans-cinnamic acid. Piperonylic acid selectively inactivate the CYP73A P450 subpopulation.
-
Liarozole
Liarozole is a cytochrome P450 (CYP450) dependent inhibitor, orally active, it also a potent inhibitor of estrogen (via inhibition of aromatase) and testicular androgen synthesis (inhibition of 17 ,20-lyase).
Cart
sales@molnova.com